SNGX

$1.57+0.64%

1M+30.8%3M+18.9%1Y-59.5%Market Cap:$6.73M

Soligenix IncHealthcare | Biotechnology

Soligenix, Inc., an advanced stage biopharmaceutical company, focuses on developing and marketing products to treat rare diseases in the United States. The company is headquartered in Princeton, New Jersey.